Case Note & Summary
The case involved appeals by the Commissioner of Central Excise, Delhi against the order of the Customs Excise and Gold (Control) Appellate Tribunal, which classified 22 products manufactured by Ishaan Research Lab Private Limited (IRLP) as Ayurvedic medicines under the Central Excise Tariff Sub-heading 3003.30, rather than as cosmetics under Chapter 33. The Revenue Department contended that these products were cosmetics and should attract a higher duty rate of 40%. The Tribunal found that IRLP and its associated companies were not related persons, thus the price at which IRLP sold the products was to be used for determining the assessable value. The Tribunal also ruled that the extended period of limitation was not applicable, leading to a re-quantification of duty based on a normal limitation period of six months. The court examined the classification of the products, the valuation, and the limitation issues, ultimately agreeing with the Tribunal's classification of the products as Ayurvedic medicines. The court emphasized that the common parlance test was not the sole determinant for classification and that the medicinal properties claimed on the product labels were significant. The court upheld the Tribunal's decision, affirming that the products were correctly classified under Chapter 30 and not Chapter 33, and noted that the Revenue failed to prove that the products were cosmetics. The court's decision reinforced the importance of the nature of the products and their intended use in determining classification under the Central Excise Tariff.
Headnote
A) Central Excise - Classification of Goods - Ayurvedic Medicines vs. Cosmetics - Products classified under Sub-heading 3003.30 as Ayurvedic medicines - Central Excise Tariff Act, 1944, Section 11A - The Tribunal held that 22 products were Ayurvedic medicines attracting 10% duty, rejecting the Revenue's claim of 40% duty under cosmetics. The court affirmed the Tribunal's findings based on the nature of the products and their medicinal claims (Paras 2-32).
Issue of Consideration
Whether the products manufactured by Ishaan Research Lab (P) Ltd. are classified as Ayurvedic medicines or cosmetics under the Central Excise Tariff.
Final Decision
The Supreme Court upheld the Tribunal's classification of the 22 products as Ayurvedic medicines under Sub-heading 3003.30, affirming that they were not cosmetics and thus not subject to the higher duty rate. The court also agreed with the Tribunal's findings regarding the valuation and limitation periods, rejecting the Revenue's claims.
Law Points
- Classification of goods
- Valuation
- Limitation
- Related persons
- Central Excise Tariff
